Stephens raised the firm’s price target on Ensign Group (ENSG) to $170 from $165 and keeps an Overweight rating on the shares. Despite Ensign contending with uncertainty surrounding the long-term Medicaid reimbursement backdrop for Skilled Nursing Facilities, fundamentals “have not wavered,” says the analyst, who raises estimates following the company’s Q2 report.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENSG:
